Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-11

FDA Approved: ATOMOXETINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for atomoxetine, enabling the marketing of a generic atomoxetine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine (Atomoxetine)

Snippet

ORIG AP for ATOMOXETINE (ATOMOXETINE)